Congenital diaphragmatic hernia (CDH) is a rare disease, which affects 1 in 2,500 newborns. Congenital diaphragmatic hernia can interfere with the normal development of the pulmonary parenchyma and vascular bed, and in severe cases, it can lead to the development of severe pulmonary arterial hypertension (PAH) and right ventricular failure. We present a neonate with CDH who developed severe PAH and right ventricular dysfunction and was managed with a unique strategy combining venoarterial extracorporeal membrane oxygenation, prostaglandin E1, and a variety of PAH therapies.
AbmanSHHansmannGArcherSL, et al.Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037–2099.
3.
VidaVLSpeggiorinSMaschiettoN, et al.Cardiac operations after patent ductus arteriosus stenting in duct-dependent pulmonary circulation. Ann Thorac Surg. 2010;90(2):605–609.
4.
CarmosinoMJFriesenRHDoranAIvyDD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg. 2007;104(3):521–527.
5.
AkkinapallySHundalaniSGKulkarniM, et al.Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev. 2018;2:Cd011417.
6.
PeledNDaganOBabynP, et al.Gastric-outlet obstruction induced by prostaglandin therapy in neonates. New Engl J Med. 1992;327(8):505–510.
7.
LawrenceKMBergerKHerkertL, et al.Use of prostaglandin E1 to treat pulmonary hypertension in congenital diaphragmatic hernia. J Pediatr Surg. 2019;54(1):55–59.
8.
VictoriaTBebbingtonMWDanzerE, et al.Use of magnetic resonance imaging in prenatal prognosis of the fetus with isolated left congenital diaphragmatic hernia. Prenat Diagn. 2012;32(8):715–723.
